drug · small molecule
patient view →SAPROPTERIN DIHYDROCHLORIDE
Marketedupdated 2mo agoby $RLFTY MindMaze Therapeutics Holding SA🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for phenylketonuria and hyperphenylalaninemia and 10 investigational indications.
targets
Phenylalanine-4-hydroxylase
all catalysts(1)
approval · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that